182 related articles for article (PubMed ID: 23946494)
1. γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer.
Fernández MI; Gong Y; Ye Y; Lin J; Chang DW; Kamat AM; Wu X
Carcinogenesis; 2013 Nov; 34(11):2543-7. PubMed ID: 23946494
[TBL] [Abstract][Full Text] [Related]
2. H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer.
Turinetto V; Pardini B; Allione A; Fiorito G; Viberti C; Guarrera S; Russo A; Anglesio S; Ruo Redda MG; Casetta G; Cucchiarale G; Destefanis P; Oderda M; Gontero P; Rolle L; Frea B; Vineis P; Sacerdote C; Giachino C; Matullo G
Mol Carcinog; 2016 Nov; 55(11):1833-1842. PubMed ID: 27439749
[TBL] [Abstract][Full Text] [Related]
3. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.
He Y; Gong Y; Lin J; Chang DW; Gu J; Roth JA; Wu X
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):443-51. PubMed ID: 23300022
[TBL] [Abstract][Full Text] [Related]
4. Measurement of DNA damage in peripheral blood by the γ-H2AX assay as predictor of colorectal cancer risk.
Zhao L; Chang DW; Gong Y; Eng C; Wu X
DNA Repair (Amst); 2017 May; 53():24-30. PubMed ID: 28291710
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment of esophageal adenocarcinoma using γ-H2AX assay.
Xu E; Gong Y; Gu J; Jie L; Ajani JA; Wu X
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1797-804. PubMed ID: 23904462
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 177Lu-DOTA-octreotate therapy-induced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors.
Denoyer D; Lobachevsky P; Jackson P; Thompson M; Martin OA; Hicks RJ
J Nucl Med; 2015 Apr; 56(4):505-11. PubMed ID: 25722453
[TBL] [Abstract][Full Text] [Related]
7. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Gassen D; Biko J; Meineke V; Reiners C; Scherthan H
J Nucl Med; 2010 Aug; 51(8):1318-25. PubMed ID: 20660387
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput γ-H2AX assay based on imaging flow cytometry.
Lee Y; Wang Q; Shuryak I; Brenner DJ; Turner HC
Radiat Oncol; 2019 Aug; 14(1):150. PubMed ID: 31438980
[TBL] [Abstract][Full Text] [Related]
9. γ-H2AX responds to DNA damage induced by long-term exposure to combined low-dose-rate neutron and γ-ray radiation.
Zhang J; He Y; Shen X; Jiang D; Wang Q; Liu Q; Fang W
Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():36-40. PubMed ID: 26774665
[TBL] [Abstract][Full Text] [Related]
10. DNA repair in modeled microgravity: double strand break rejoining activity in human lymphocytes irradiated with gamma-rays.
Mognato M; Girardi C; Fabris S; Celotti L
Mutat Res; 2009 Apr; 663(1-2):32-9. PubMed ID: 19428367
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.
Djuzenova CS; Elsner I; Katzer A; Worschech E; Distel LV; Flentje M; Polat B
Radiat Oncol; 2013 Apr; 8():98. PubMed ID: 23617930
[TBL] [Abstract][Full Text] [Related]
12. Gamma-radiation sensitivity and risk of glioma.
Bondy ML; Wang LE; El-Zein R; de Andrade M; Selvan MS; Bruner JM; Levin VA; Alfred Yung WK; Adatto P; Wei Q
J Natl Cancer Inst; 2001 Oct; 93(20):1553-7. PubMed ID: 11604478
[TBL] [Abstract][Full Text] [Related]
13. Mean frequency and relative fluorescence intensity measurement of γ-H2AX foci dose response in PBL exposed to γ-irradiation: An inter- and intra-laboratory comparison and its relevance for radiation triage.
Venkateswarlu R; Tamizh SG; Bhavani M; Kumar A; Alok A; Karthik K; Kalra N; Vijayalakshmi J; Paul SF; Chaudhury NK; Venkatachalam P
Cytometry A; 2015 Dec; 87(12):1138-46. PubMed ID: 26305808
[TBL] [Abstract][Full Text] [Related]
14. Genetic instability in bladder cancer assessed by the comet assay.
Schabath MB; Spitz MR; Grossman HB; Zhang K; Dinney CP; Zheng PJ; Wu X
J Natl Cancer Inst; 2003 Apr; 95(7):540-7. PubMed ID: 12671022
[TBL] [Abstract][Full Text] [Related]
15. Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity.
van Oorschot B; Hovingh SE; Moerland PD; Medema JP; Stalpers LJ; Vrieling H; Franken NA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):664-70. PubMed ID: 24411188
[TBL] [Abstract][Full Text] [Related]
16. Validation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical applications.
Johansson P; Fasth A; Ek T; Hammarsten O
Cytometry B Clin Cytom; 2017 Nov; 92(6):534-540. PubMed ID: 27060560
[TBL] [Abstract][Full Text] [Related]
17. The profiles of gamma-H2AX along with ATM/DNA-PKcs activation in the lymphocytes and granulocytes of rat and human blood exposed to gamma rays.
Wang J; Yin L; Zhang J; Zhang Y; Zhang X; Ding D; Gao Y; Li Q; Chen H
Radiat Environ Biophys; 2016 Aug; 55(3):359-70. PubMed ID: 27260225
[TBL] [Abstract][Full Text] [Related]
18. Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation.
Sak A; Grehl S; Engelhard M; Wierlemann A; Kaelberlah HP; Erichsen P; Pöttgen C; Groneberg M; Stuschke M
Clin Cancer Res; 2009 Apr; 15(8):2927-34. PubMed ID: 19336520
[TBL] [Abstract][Full Text] [Related]
19. Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.
van Oorschot B; Hovingh S; Dekker A; Stalpers LJ; Franken NA
Radiat Res; 2016 Feb; 185(2):190-8. PubMed ID: 26789702
[TBL] [Abstract][Full Text] [Related]
20. Adapting the γ-H2AX assay for automated processing in human lymphocytes. 1. Technological aspects.
Turner HC; Brenner DJ; Chen Y; Bertucci A; Zhang J; Wang H; Lyulko OV; Xu Y; Shuryak I; Schaefer J; Simaan N; Randers-Pehrson G; Yao YL; Amundson SA; Garty G
Radiat Res; 2011 Mar; 175(3):282-90. PubMed ID: 21388271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
